Stock Events

Stock Events

Nexstim 

0
0
+SEK0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14AugExpected
Q2 2025
Q4 2025
Q2 2026
-1.3
-0.41
0.49
1.38
Expected EPS
-1.3047578676
Actual EPS
-0.5436491115000001

Financials

5.08%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
120.11MRevenue
6.1MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXTMS-BTA.ST. It's not an investment recommendation.
Microsoft
2
MSFT
Tesla
2
TSLA
Alphabet
2
GOOGL
Bitcoin
2
BTC.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Nemaura Medical
NMRD
Mkt Cap4,035
Nemaura Medical Inc. competes with Nexstim in the development of medical devices for the healthcare sector, focusing on diabetes management which overlaps with Nexstim's focus on therapeutic and diagnostic medical devices.
Neogen
NEOG
Mkt Cap2.54B
Neogen Corporation offers products for food and animal safety testing, which indirectly competes with Nexstim's focus on innovative health technologies and diagnostics.
Inogen
INGN
Mkt Cap145.96M
Inogen, Inc. provides portable oxygen concentrators for patients requiring respiratory therapy, indirectly competing with Nexstim's therapeutic devices in the broader healthcare equipment sector.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc offers medical technologies, services, and solutions, including neuromodulation devices that compete with Nexstim's navigated brain stimulation technology for therapeutic uses.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with Nexstim in the neuromodulation and neurostimulation device market.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. focuses on pharmaceuticals for central nervous system disorders among other areas, competing with Nexstim's non-drug therapies for similar conditions.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical technologies, including neurotechnology and spine products, directly competing with Nexstim's offerings in the neurostimulation and neuromodulation market.

About

Nexstim Plc, a medical technology enterprise, specializes in the creation and global distribution of non-invasive brain stimulation technologies, with operations spanning Finland, Europe, North America, and other international markets. Central to its offerings is the proprietary SmartFocus technology, featuring 3D navigation, which underpins its navigated transcranial magnetic stimulation (TMS) approach utilized for both therapeutic interventions and diagnostic assessments. The company provides two distinct systems: the NBT system, a navigated brain therapy solution designed for addressing major depression and chronic neuropathic pain, and the NBS system, a navigated brain stimulation device engineered for precise pre-surgical mapping of the brain's speech and motor cortices. Nexstim predominantly sells its NBS systems to academic institutions and teaching hospitals. Established in 2000, Nexstim Plc's corporate headquarters are located in Helsinki, Finland.
Show more...
CEO
Mikko Karvinen
Employees
44
Country
Finland
ISIN
SE0014401055

Listings

ST
SE
NXTMS-BTA.ST
MU
DE
5NX.MU
STU
DE
5NX.STU
HE
FI
NXTMH.HE

0 Comments

Share your thoughts

FAQ

What is Nexstim stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Nexstim stocks are traded under the ticker NXTMS-BTA.ST.
When is the next Nexstim earnings date?▼
Nexstim is going to release the next earnings report on March 01, 2027.
What were Nexstim earnings last quarter?▼
NXTMS-BTA.ST earnings for the last quarter are -0.54 SEK per share, whereas the estimation was -1.3 SEK resulting in a +58.33% surprise. The estimated earnings for the next quarter are N/A SEK per share.
What is Nexstim revenue for the last year?▼
Nexstim revenue for the last year amounts to 120.11M SEK.
What is Nexstim net income for the last year?▼
NXTMS-BTA.ST net income for the last year is 6.1M SEK.
How many employees does Nexstim have?▼
As of September 04, 2026, the company has 44 employees.
In which sector is Nexstim located?▼
Nexstim operates in the Health & Wellness sector.
When did Nexstim complete a stock split?▼
Nexstim has not had any recent stock splits.
Where is Nexstim headquartered?▼
Nexstim is headquartered in Helsinki, Finland.